Human papilloma virus in head and neck cancers-role and relevance in clinical management.

Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics. PLoS One (2015) 0.80

HPV-Related Retroperitoneal Squamous Cell Carcinoma of Unknown Primary: A Case Report. Cancer Res Treat (2015) 0.80

Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer. Viruses (2015) 0.79

HPV-16 infection modifies overall survival of Puerto Rican HNSCC patients. Infect Agent Cancer (2016) 0.77

X-linked FHL1 as a novel therapeutic target for head and neck squamous cell carcinoma. Oncotarget (2016) 0.75

Human Papilloma Virus' Life Cycle and Carcinogenesis. Maedica (Buchar) (2016) 0.75

Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med (2010) 22.74

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77

Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10

Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97

Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer (2009) 4.50

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer (2007) 3.98

Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst (2004) 3.67

Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum (2007) 3.30

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer (2008) 3.16

Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer (2008) 2.67

Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci (2006) 2.56

Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2001) 2.24

Changes in sexual behaviours: from secular trends to public health policies. AIDS (2010) 2.17

Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol (2005) 1.97

HPV infections and tonsillar carcinoma. J Clin Pathol (2004) 1.76

Evaluation of human papillomavirus testing for squamous cell carcinoma of the tonsil in clinical practice. J Clin Pathol (2011) 1.70

The role of human papillomavirus in the increased incidence of base of tongue cancer. Int J Cancer (2010) 1.69

Prevalence of heavy smoking in California and the United States, 1965-2007. JAMA (2011) 1.68

Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer (2002) 1.66

Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis. Int J Oral Surg (1983) 1.65

Head and neck cancer: past, present and future. Expert Rev Anticancer Ther (2006) 1.63

Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer (2003) 1.57

Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer (2011) 1.41

Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population: the British Columbia experience. Cancer (2010) 1.40

The role of human papillomavirus in oral carcinogenesis. Crit Rev Oral Biol Med (2004) 1.31

Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas. Laryngoscope (2009) 1.27

Complex etiology underlies risk and survival in head and neck cancer human papillomavirus, tobacco, and alcohol: a case for multifactor disease. J Oncol (2012) 1.27

Temporal trends in sexual behaviors and sexually transmitted disease history among 18- to 39-year-old Seattle, Washington, residents: results of random digit-dial surveys. Sex Transm Dis (2005) 1.20

Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection. Curr Opin Oncol (2009) 1.18

Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2011) 1.16

Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer (2010) 1.15

Detection of HPV-16 genome in human oral cancers and potentially malignant lesions from India. Oral Oncol (1998) 1.15

Human papillomaviruses in 91 oral cancers from Indian betel quid chewers--high prevalence and multiplicity of infections. Int J Cancer (1995) 1.14

Papillomavirus infections and human genital cancer. Gynecol Oncol (1981) 1.10

Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer (2002) 1.06

Oropharyngeal cancer - is it time to change management according to human papilloma virus status? Curr Opin Otolaryngol Head Neck Surg (2012) 1.04

Radiosensitization of oropharyngeal squamous cell carcinoma cells by human papillomavirus 16 oncoprotein E6∗I. Int J Radiat Oncol Biol Phys (2010) 1.00

Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol Carcinog (1994) 0.97

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation. Ann Oncol (2009) 0.95

Sexual behaviour and related knowledge among a representative sample of secondary school students between 1997 and 2008. Aust N Z J Public Health (2010) 0.93

Development of a condemned mucosa syndrome and pathogenesis of human papillomavirus-associated upper aerodigestive tract and uterine cervical tumors. Exp Mol Pathol (2000) 0.91

Immunotherapy for head and neck cancer. J Biomed Sci (2008) 0.88

A targeted approach to a giant gastrointestinal stromal tumor of the esophagus. Indian J Surg Oncol (2013) 0.76

Stapler closure technique for laryngectomy-revisited. Indian J Surg Oncol (2012) 0.75

Parotid gland metastasis from a rectal carcinoma. Indian J Surg Oncol (2013) 0.75

Chest wall metastasis resulting from a primary extremity osteosarcoma- a dramatic clinical presentation. Indian J Surg Oncol (2013) 0.75